BCL3 over-expression contributes an in vivo growth advantage in a B-cell lymphoma xenograft model and is a risk factor for ibrutinib relapse in CLL

被引：0
|
作者：
Chen, Timothy L.
Harrington, Bonnie K.
Beaver, Larry
Ruppert, Amy S.
Heerema, Nyla A.
Zhang, Xiaoli
Ozer, Hatice Gulcin
Johnson, Amy J.
Woyach, Jennifer A.
Hertlein, Erin
Byrd, John C.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3014
引用
收藏
页数：2
相关论文
共 12 条
  • [1] BCL3 rearrangement, amplification and expression in diffuse large B-cell lymphoma
    Ibrahim, Hazem A. H.
    Amen, Furrat
    Reid, Alistair G.
    Naresh, Kikkeri N.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (06) : 480 - 485
  • [2] A rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma
    Ohno, Hitoshi
    Nakagawa, Miho
    Kishimori, Chiyuki
    Fukutsuka, Katsuhiro
    Hayashida, Masahiko
    Izumi, Kiyotaka
    Akasaka, Takashi
    Honjo, Gen
    Haga, Hironori
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 825 - 828
  • [3] Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma
    Li, Changping
    Thompson, Michael A.
    Tamayo, Archito T.
    Zuo, Zhuang
    Lee, John
    Vega, Francisco
    Ford, Richard J.
    Pham, Lan V.
    ONCOTARGET, 2012, 3 (03) : 314 - 326
  • [4] Activation of rat and human organic anion transporter 1 and 3 by transcription factor B-cell CLL/lymphoma 6 (BCL6)
    Henjakovic, Maja
    Wegner, Waja
    Burckhardt, Birgitta C.
    Burckhardt, Gerhard
    FASEB JOURNAL, 2013, 27
  • [5] Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats
    El-Bahr, Sabry M.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13
  • [6] Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats
    Sabry M El-Bahr
    BMC Complementary and Alternative Medicine, 13
  • [7] B-cell over-expression of tyrosine phosphatase NE-3 contributes to impaired insulin release in type 2 diabetic Goto-Kakizaki (GK) rats
    Östenson, CG
    Sandberg-Nordqvist, AC
    Hällbrink, M
    Langel, U
    Efendic, S
    DIABETOLOGIA, 2000, 43 : A130 - A130
  • [8] EBV-positive nodal low-grade B-cell lymphoma with BCL3, IgA and IRTA1 expression: Is this a polymorphic lymphoproliferative disorder or an EBV-positive nodal marginal zone lymphoma?
    Fujimoto, Masakazu
    Yamashita, Yusuke
    Haga, Hironori
    Akasaka, Takashi
    Iwahashi, Yoshifumi
    Warigaya, Kenji
    Kojima, Fumiyoshi
    Hama, Yuya
    Tamura, Shinobu
    Sonoki, Takashi
    Murata, Shin-ichi
    PATHOLOGY INTERNATIONAL, 2018, 68 (09) : 538 - 540
  • [9] B-Cell Lymphoma-2 Over-Expression Protects δ-Elemene-Induced Apoptosis in Human Lung Carcinoma Mucoepidermoid Cells via a Nuclear Factor Kappa B-Related Pathway
    Xie, Chun Ying
    Yang, Wei
    Ying, Jun
    Ni, Qing Chun
    Pan, Xue Diao
    Dong, Jin Hua
    Li, Karen
    Wang, Xi Sha
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) : 1279 - 1286
  • [10] MYC/BCL2 DOUBLE EXPRESSION INCREASES A RISK OF RELAPSE OR PROGRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY M-NHL-BFM-90 PLUS RITUXIMAB
    Misyurina, A.
    Kovrigina, A.
    Baryakh, E.
    Misyurin, V.
    Kravchenko, S.
    Misyurin, A.
    Kulikov, S.
    Obukhova, T.
    Denisov, N.
    Denisova, J.
    Magomedova, A.
    Vorobiev, V.
    Mangasarova, Y.
    Gemdzhian, E.
    HAEMATOLOGICA, 2015, 100 : 399 - 400
12